Skip to main content
Volunteer performing visual field test using a home PC running Melbourne Rapid Fields software
Nov 2022
Positive Results for World-First At Home Glaucoma Monitoring Trial

A 12-month clinical trial to examine the validity of home-monitoring for glaucoma patients using a novel software app has been successfully completed by a team of Australian researchers. 

Click this to read more.
Image of Dr David Weschler
Nov 2022
Q&A: How to Prepare Yourself for Laser and Surgery

Sydney-based ophthalmologist, Dr David Weschler, recently took part in a Live Q&A with Glaucoma Australia where he answered some of the most commonly asked questions about laser and surgery.

Click this to read more.
Image of a man driving
Oct 2022
Updates to Australia’s Fitness to Drive Criteria

Glaucoma can affect our vision and the ability to drive safely. It is important to be aware of how glaucoma can influence driving as well as the standard your vision must meet to be able to legally hold a driver’s licence.

Click this to read more.
Image of a woman driving
Oct 2022
Margaret's Story

We relocated in late 2020, so I had to find a new eye specialist. 

Click this to read more.
Image of reading glasses on top of books
Oct 2022
Lesley's Story

Since being diagnosed with glaucoma, I have been using several types of eye drops for 42 years.

Click this to read more.
Image of Dr Owen Siggs
Oct 2022
Glaucoma Australia to Fund Promising Genomic Risk Stratification Research

To commemorate 'World Sight Day', Glaucoma Australia and its Patron, the Governor-General of Australia, His Excellency the Honourable David Hurley, are pleased to announce the 2022 recipient of the charity’s ‘Quinlivan’ Research Grants Program. 

Click this to read more.
Image of Ty Nuygen
Oct 2022
Eye Drop Compliance Vital in Curbing Rapid Vision Loss for Melbourne Mum

To celebrate World Sight Day and this year’s theme of #loveyoureyes, the Royal Victorian Eye and Ear Hospital has shared the story of one of their glaucoma patients with the hopes of raising awareness about the importance of eye-drop treatment adherence. 

Click this to read more.
Image of the iDose TR
Sep 2022
A Promising Alternative to Daily Eye drops? Positive Outcomes for Phase 3 ...

Glaukos Corporation has announced positive data for Phase 3 trials of iDose TR. 

Click this to read more.
An image of reading glasses and a reading chart
Sep 2022
Christine's Story

My sister, who is four years older than I am, went to her local hospital, the Queen Elizabeth in Glasgow, Scotland.

Click this to read more.